Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 12 EP applications Sabine Venne-Dunker has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after January 23, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11757858

SUBSTITUTED 4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[4,3-C]PYRIDINES, THEIR USE AS MEDICAMENT, AND PHARMACEUTICAL PREPARATIONS COMPRISING THEM

IPC classification:
A61K 31/437, A61K 31/439, A61P 9/06, C07D 471/04, C07D 471/18
Applicant:
Sanofi, S.A.
Agent:
Sabine Venne-Dunker, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11757271

INDANYL-SUBSTITUTED 4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[4,3-C]PYRIDINES, THEIR USE AS MEDICAMENT, AND PHARMACEUTICAL PREPARATIONS COMPRISING THEM

IPC classification:
A61K 31/4353, A61P 9/06, A61P 25/28, C07D 471/04
Applicant:
Sanofi, S.A.
Agent:
Sabine Venne-Dunker, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12759725

N-[4-(1H-PYRAZOLO[3,4-B]PYRAZIN-6-YL)-PHENYL]-SULFONAMIDES AND THEIR USE AS PHARMACEUTICALS

IPC classification:
A61K 31/4985, A61P 19/02, C07D 487/04
Applicant:
Sanofi, S.A.
Agent:
Multiple attorneys, Sanofi-Aventis Deutschland GmbH
Status:
The patent has been granted
EP12794728

CRYSTALLINE FORMS OF 2-(2-METHYLAMINO-PYRIMIDIN-4-YL)-1H-INDOLE-5-CARBOXYLIC ACID [(S)-1-CARBAMOYL-2-(PHENYL-PYRIMIDIN-2-YL-AMINO)-ETHYL]-AMIDE

IPC classification:
A61K 31/506, A61P 29/00, C07D 403/14
Applicant:
Sanofi, S.A.
Agent:
Sabine Venne-Dunker, Sanofi-Aventis Deutschland GmbH
Status:
PATENT GRANTED
EP12806043

ISOTHIAZOLOPYRIDINE-2-CARBOXAMIDES AND THEIR USE AS PHARMACEUTICALS

IPC classification:
A61K 31/4745, A61K 31/496, A61K 31/498, A61K 31/53, A61K 31/5377, A61P 19/00, A61P 25/00, A61P 35/00, C07D 513/00, C07D 513/04
Applicant:
Sanofi, S.A.
Agent:
Sabine Venne-Dunker, Sanofi-Aventis Deutschland GmbH
Status:
PATENT GRANTED
EP13702225

FUSED PYRROLEDICARBOXAMIDES AND THEIR USE AS PHARMACEUTICALS

IPC classification:
A61K 31/429, A61K 31/437, A61K 31/5365, A61K 31/5383, A61K 31/542, A61P 9/06, A61P 11/00, C07D 471/04, C07D 498/04, C07D 513/04
Applicant:
Sanofi, S.A.
Agent:
Sabine Venne-Dunker, Sanofi-Aventis Deutschland GmbH
Status:
PATENT GRANTED
EP13723767

BENZO[1,3]DIOXINE DERIVATIVES AND THEIR USE AS LPAR5 ANTAGONISTS

IPC classification:
A61K 31/357, A61K 31/4025, A61K 31/41, A61K 31/4433, A61P 9/00, C07D 319/08, C07D 401/04, C07D 401/12, C07D 403/04, C07D 403/12, C07D 413/04
Applicant:
Sanofi, S.A.
Agent:
Sabine Venne-Dunker, Sanofi-Aventis Deutschland GmbH
Status:
EXAMINATION IN PROGRESS
EP13723150

PYRIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CONDITIONS ASSOCIATED WITH PATHOLOGICAL THROMBUS FORMATION

IPC classification:
A61K 31/4418, A61P 7/02, C07D 213/30
Applicant:
Sanofi, S.A.
Agent:
Sabine Venne-Dunker, Sanofi-Aventis Deutschland GmbH
Status:
GRANT OF PATENT INTENDED
EP13723151

PYRAZOLE DERIVATIVES AND THEIR USE AS LPAR5 ANTAGONISTS

IPC classification:
A61K 31/415, A61K 31/4155, A61P 7/02, C07D 231/12, C07D 409/04
Applicant:
Sanofi, S.A.
Agent:
Sabine Venne-Dunker, Sanofi-Aventis Deutschland GmbH
Status:
PATENT GRANTED
EP14711467

N-(4-(AZAINDAZOL-6-YL)-PHENYL)-SULFONAMIDES AND THEIR USE AS PHARMACEUTICALS

IPC classification:
A61K 31/437, A61K 31/52, A61P 9/00, A61P 19/02, C07D 471/04, C07D 487/04
Applicant:
Sanofi, S.A.
Agent:
Multiple attorneys, Sanofi-Aventis Deutschland GmbH
Status:
PATENT GRANTED
EP14729285

MACROCYCLIC UREA DERIVATIVES AS INHIBITORS OF TAFI A, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS

IPC classification:
A61K 31/553, A61P 7/00, C07D 273/01, C07D 413/12
Applicant:
Sanofi, S.A.
Agent:
Sabine Venne-Dunker, Sanofi-Aventis Deutschland GmbH
Status:
The patent has been granted
EP15731617

2-(2-METHYLAMINO-PYRIMIDIN-4-YL)-1H-INDOLE-5-CARBOXYLIC ACID [(S)-1-CARBAMOYL-2-(PHENYL-PYRIMIDIN-2-YL-AMINO)-ETHYL]-AMIDE FOR USE IN THE TREATMENT OF PAIN ASSOCIATED TO OSTEOARTHRITIS

IPC classification:
A61K 31/506, A61P 19/02
Applicant:
Sanofi, S.A.
Agent:
Sabine Venne-Dunker, Sanofi-Aventis Deutschland GmbH
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature